IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2020 Holdings

Filed 2020-11-17 | 11 holdings | $39.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2020-12-08) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$38.9M137,16399.3%
Regeneron Pharmaceuticals(REGN)COM75886F107$46.0K82,2580.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$45.4K396,5750.1%
United Therapeutics Corp(UTHR)ACOM91307C102$43.0K426,2150.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$37.8K825,3290.1%
Taro Pharmaceutical IndusCOMM8737E108$29.5K537,3780.1%
Mckesson Corp(MCK)COM58155Q103$27.7K186,0300.1%
Alkermes PLC(ALKS)COMG01767105$26.1K1,572,3950.1%
Surgalign Holdings IncCOM86882C105$11.3K6,251,2080.0%
Invacare CorpCOM461203101$6.6K880,9200.0%
Anaptysbio Inc(ANAB)COM032724106$1.8K118,8580.0%